Polymeric Fill Matrix for Softgel Capsule Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional softgel capsule formulations face issues such as degradation of active ingredients due to water migration from the shell, interactions between fill and shell components, and require extensive drying processes, which are time-consuming and resource-intensive. Additionally, existing polymeric fill materials do not disintegrate or dissolve in the gastrointestinal tract, leading to intestinal problems.
Innovation Solution
A softgel formulation using a polymeric fill matrix formed from activated monomers without water, which minimizes interactions between fill and shell components, reduces water migration, and is sensitive to pH, allowing for immediate or delayed release of active ingredients. This matrix is formed through polymerization of monomers, solvents, and photoinitiators, eliminating the need for cross-linking agents and reducing drying time.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If a traditional softgel shell containing water is used, then the shell provides good flexibility and digestibility, but water migrates from the shell to the fill causing degradation of hydrolysis-sensitive active ingredients
Solution Approach 1:
The patent removes water from the fill formulation by using a non-aqueous polymeric matrix system. The fill contains no water, thereby eliminating the source of water migration that causes hydrolysis of sensitive active ingredients like aspirin, while the gelatin shell retains its water content for flexibility and digestibility.
Solution Approach 2:
The patent uses a composite polymeric matrix formulation consisting of multiple polymers (such as polyethylene glycol, polyvinyl alcohol, carboxymethyl cellulose) combined with excipients to create a water-free or low-water fill system that maintains structural integrity and drug stability without relying on aqueous solutions.
2Ease of manufacture
If a traditional liquid or suspension fill is used, then the formulation is easy to manufacture, but extensive drying processes are required which are time-consuming and resource-intensive
Solution Approach 1:
The patent changes the fundamental parameter of the fill system from aqueous-based to polymeric matrix-based. This transformation eliminates the need for extensive drying processes because the polymeric matrix inherently binds and retains moisture, allowing the softgel to be filled in a semi-solid or solid state without requiring prolonged drying to achieve low moisture content.
3Reliability
If existing polymeric fill materials are used, then water migration is reduced, but the materials do not disintegrate or dissolve in the gastrointestinal tract causing intestinal problems
Solution Approach 1:
The patent creates a dynamic polymeric matrix system that remains stable during storage and manufacturing (preventing water migration) but transforms into a disintegrating structure in the gastrointestinal environment. The polymeric composition is specifically selected to dissolve or break down into safe, excretable components after ingestion, eliminating intestinal obstruction risks.
Solution Approach 2:
The patent applies different properties to the polymeric matrix at different stages: during storage and handling, the matrix maintains structural integrity and low water content; upon contact with gastrointestinal fluids, the matrix becomes soluble and disintegrates. This spatial and temporal differentiation of material properties resolves the contradiction between stability and biodegradability.
4Reliability
If a polymeric fill matrix formed from activated monomers without water is used, then interactions between fill and shell components are minimized and water migration is reduced, but the formulation complexity increases
Solution Approach 1:
The patent employs polymeric materials that serve multiple functions simultaneously: they provide structural matrix support, bind excipients and active ingredients, prevent water migration, and ensure gastrointestinal solubility. This multi-functionality reduces the need for separate components and simplifies the overall formulation despite the advanced chemistry involved.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution provides stable, fast-release, delayed-release, or sustained-release formulations that prevent intestinal issues, reduce manufacturing time and resources, and ensure the stability of hydrophilic drugs, while allowing for a wide range of excipients and active ingredients, including naproxen, acetylsalicylic acid, and ibuprofen.
Implementation Method 1
The polymeric fill matrix is formed from activated monomers... This matrix is formed through polymerization of monomers, solvents, and photoinitiators
Implementation Method 2
minimizes interactions between fill and shell components, reduces water migration
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
Stable dosage forms, preferably of pharmaceutical formulations, that include a solid or semi-solid polymeric mass, which entraps active ingredients and can be formulated for oral administration in a mould, preferably in a softgel capsule.